Uterine secretions have a dominant impact on the environment in which embryo development takes place. The uterine serpins (SERPINA14, previously known as UTMP) are found most abundantly during pregnancy in the uterus of ruminants. Although progesterone is currently assumed to be the major regulator of SERPINA14 expression, our recent study of transcriptome changes in bovine endometrium during the estrous cycle unexpectedly detected a marked upregulation of SERPINA14 mRNA levels at estrus. The present study describes the full-length mRNA sequence, genomic organization, and putative promoter elements of the SERPINA14 gene. The SERPINA14 mRNA abundance was quantified by real-time RT-PCR in intercaruncular endometrium at several time points during the estrous cycle and early pregnancy. Highest levels were found at estrus, followed by a dramatic decrease and a moderate expression during the luteal phase. Transcript levels were higher in pregnant endometrium compared with controls at Day 18. At estrus, immunoreactive protein was localized in deep glandular epithelium, and Western blotting concomitantly showed the 52-kDa form in uterine flushings. SERPINA14 mRNA was significantly upregulated in glandular endometrial cells in vitro after stimulation with estradiol-17beta and progesterone, but not after interferon-tau treatment. Our results clearly demonstrate that SERPINA14 appears distinctly in bovine endometrium during the estrus phase. A supporting role toward providing a well-prepared endometrial environment for passing gametes, especially sperm, is assumed.
INTRODUCTION
An intact uterine environment is of crucial importance for reproductive success. During the estrous cycle, the endometrium undergoes a locally and timely synchronized reorganization to meet the needs of the gametes and the early developing conceptus. The synthesis and excretion of histotroph by the endometrium is crucial as nutritious fluid and provides a means for the communication between conceptus and maternal environment through signaling molecules. The uterine serpins/ uterine milk proteins (serpin peptidase inhibitor, clade A [alpha-1 antiproteinase, antitrypsin], member 14; SERPINA14) are basic glycoproteins that are members of the serpin superfamily of serine peptidase inhibitors (serpins). SERPINA14 molecules were initially described in the 1980s as ovine uterine serpins (OvUS) of the sheep uterus that were the major secretory proteins expressed in the endometrium during pregnancy in ruminants [1, 2] . Thereafter, much effort has been undertaken to purify and characterize SERPINA14.
The secreted SERPINA14 protein exhibits different isoforms with similar molecular weights encoded from one single gene that only differ in their glycosylation pattern [3] . They contain several carbohydrate residues [4] and are susceptible to protease degradation [5] . Ruminant SERPINA14 possesses phosphorylated oligosaccharide chains, normally a characteristic feature of lysosomal hydrolases. Neither enzymatic activity nor a distinct target for the inhibition of serine peptidases has been described to date [6] . However, the serpins are a family of structurally related proteins that have a large number of different functions [7] . Several consistent reports show that SERPINA14 is secreted by the glandular epithelium in ovine as well as bovine pregnant endometrium [8, 9] . Convincing evidence has been provided that the secretion of SERPINA14 is progesterone (P4) dependent starting as early as Day 16 of pregnancy in sheep. SERPINA14 mRNA has been demonstrated by in situ hybridization only sparsely at Days 13 and 15 of the estrous cycle in the ewe [10] ; however, a longterm P4 treatment led to a prominent induction of SERPINA14 in sheep and cattle [2, 9, 11] . Long-term combined treatment of ovariectomized ewes with estradiol-17b (E2) and P4, however, exhibited no stimulatory effect on SERPINA14 expression in the ovine uterus but increased endometrial P4 receptor and decreased SERPINA14 mRNA expression compared with treatment with P4 alone [12] . A possible prerequisite for inducing ovine SERPINA14 might therefore be a reduction of endometrial P4 receptor (PGR) [12] .
The well-known uterine immunosuppressive action of P4 is attributed, at least in part, to SERPINA14 [13] . SERPINA14 has been ascribed to inhibit lymphocyte function in vitro, thus enabling maternal immunological tolerance toward the conceptus [14] . Although it is not the predominant protein during pregnancy in the cow, the presence of substantial amounts of SERPINA14 in bovine uterine histotroph during pregnancy, with likewise immunosuppressive activity as in sheep, has been demonstrated successfully [15] . Mitogen-stimulated lymphocyte proliferation was decreased in the presence of SERPINA14 in vitro [15] [16] [17] , and growth of a tumor cell line was inhibited as well [18] . A reduction by SERPINA14 of the activity of uterine natural killer-like cells was demonstrated in vitro [19, 20] , whereas the proliferation of cd-T cells-a subset of lymphocytes that does not recognize major histocompatibility complex molecules and which is associated with beneficial cytokine production during pregnancy-was not impaired [21] . Ovine SERPINA14 has been shown to form complexes with immunoglobulin A (IgA) and IgM, thereby possibly preventing antibody-mediated actions against the conceptus semiallograft [22] . The mechanisms of immune modulation, however, remain mostly unclear, because no specific receptor for SERPINA14 has yet been described.
In our recent differential gene expression analyses in bovine endometrium, the SERPINA14 mRNA was found at markedly higher levels at estrus when high levels of estrogens were present than during the P4-dominated diestrus phase [23, 24] , although previous studies had consistently reported an increase in SERPINA14 expression with rising P4 concentrations during pregnancy [1, 2] . Additionally, comparing cyclic with pregnant endometrium at Day 18, SERPINA14 mRNA was upregulated during the preimplantation phase, where yet equal levels of P4 prevail [25] . Therefore, estrogens and trophoblast-derived interferon-s (IFNT) were questioned as important regulators of SERPINA14 expression in the bovine endometrium. The present study was undertaken to comprehensively and quantitatively characterize SERPINA14 expression in the bovine endometrium during the estrous cycle and early pregnancy prior to implantation.
MATERIALS AND METHODS

Pretreatment of Animals and Collection of Endometrial Tissue Samples
All experiments were performed in accordance with the International Guiding Principles for Biomedical Research Involving Animals, as proposed by the Society for the Study of Reproduction, and with the European Convention on Animal Experimentation. Cyclic heifers (Deutsches Fleckvieh) between 17 and 22 mo old were cycle synchronized by an intramuscular injection of a single dose of 500 mg of cloprostenol (Estrumate; Essex Tierarznei, Munich, Germany) at diestrus. Animals were observed for sexual signs (i.e., toleration, sweating, vaginal mucus) to determine standing heat, which occurred around 60 h after Estrumate injection. In addition, animals were checked with ultrasoundguided follicle monitoring.
Experiment A
Blood samples were taken at Day 20 and Day 0 of the estrous cycle and just before slaughtering to determine serum P4 [26] and E2 [27] levels. The cycling animals were slaughtered at estrus (Day 0) and at 3.5 or 12 days after estrus, respectively (n ¼ 4 per group). The pregnant groups of animals were inseminated with cryopreserved sperm at estrus (AI) and slaughtered at Days 15 and 18 of gestation, respectively (n ¼ 4 per group). For these two groups, two control groups (n ¼ 4) were inseminated with the supernatant of centrifuged sperm derived from the same bull and also were slaughtered at Days 15 and 18 of the estrous cycle, respectively. From the Day 18 animals, a late luteal phase group (18P4H) was assigned displaying P4 concentrations .2.8 ng/ml, whereas animals of the early estrus group (18P4L), which were also slaughtered 18 days after estrus, had low P4 concentrations (,0.7 ng/ml). One animal was slaughtered at 150 days of pregnancy. The obtained uteri were flushed with 100 ml of PBS (;218C). Animals were excluded from the study if no intact conceptus was detected in case of AI. Flushing fluid was centrifuged at 800 3 g for 10 min and stored at À208C until further investigation. The uteri were opened longitudinally and divided into corpus and caudal, middle, and cranial part of the ipsilateral uterine horn for the collection of the intercaruncular endometrium samples, as described previously [23] .
Experiment B
Blood samples were taken from six animals at Day 20 of the estrous cycle and at 0, 12, 24, 36, 42, 48, 54, 60, 66 , and 72 h after Estrumate injection to determine hormone profiles of P4, E2, and luteinizing hormone (LH) [28] after induced luteolysis. At 48 and 60 h after Estrumate injection, the uteri of these animals were flushed with 20 ml of PBS after insertion of an embryo-transfer catheter in the ipsilateral uterine horn. Flushing fluid was centrifuged at 800 3 g for 10 min and stored at À208C until further investigation.
5
0 Sequence Analysis of SERPINA14
Total RNA from endometrial tissue samples was isolated as described previously [29] . The 5 0 -cDNA sequencing of SERPINA14 was performed using the SMART-RACE cDNA kit (BD Bioscience Clontech, Palo Alto, CA) introducing the total RNA of bovine endometrium. A total of 1 lg of RNA was used for the first-strand synthesis of full-length RACE-ready 5 0 and 3 0 cDNAs. These were subsequently used to perform 5 0 and 3 0 RACE touch-down PCR. Resulting PCR products were cloned using TOPO TA Cloning (Invitrogen) and were sequenced subsequently (Sequencing Service Department Biologie, Ludwig Maximilians University, München, Germany). The alignment of the partial putative SERPINA14 sequences was done using AutoAssembler 2.0 (Applied Biosystems, Foster City, CA). The SERPINA14 promoter sequence 1 kb upstream of the transcription start site was analyzed for the prediction of transcription factor-binding sites using MatInspector (http://www.genomatix. de) and TESS (Transcription Element Search System; http://www.cbil.upenn. edu/cgi-bin/tess/tess).
RNA Extraction, PCR, and RT-PCR
A two-step quantitative real-time RT-PCR was undertaken as described recently [29] . Semiquantitative conventional PCR was performed [30] [31] , complement factor C1R, and interferonstimulated gene 15 (ISG15) [25] were performed as described previously. The cycle number (CP) required achieving a definite SYBR Green fluorescence signal was calculated by the second derivative maximum method (LightCycler software, version 3.5.28). The CP is correlated inversely with the logarithm of the initial template concentration.
Data Analysis of RT-PCR
Results are presented as means 6 SEM (n ¼ 4). The CPs determined for the target genes were normalized against the housekeeping gene Ubiquitin (DCP). The Day 3.5 group of animals with the lowest expression was set as 1, and differences from all other groups are expressed by the x-fold difference [32] . For statistical analysis, the SAS program package release 9.1.3 (2002; SAS Institute Inc., Cary, NC) was used. The model included the treatment, the individual animal, and the uterus segment. For the comparison of different days, the animal entered the model as a repeated factor using the covariance structure compound symmetry. Differences between days of the cycle were localized using the least significant difference test. The differences between the segments were calculated independently for each day. Differences were considered significant at P , 0.05. Graphs were plotted with SigmaPlot 8.0 (SPSS Software GmbH, Munich, Germany).
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Generation of SERPINA14-Specific Antibody
The SERPINA14 peptide VEDEKTQRDLFVGKVLNPQVE (corresponding to amino acids 439-459 of bovine SERPINA14; Swiss-Prot accession no. P46201) was synthesized and C-terminally coupled to a proprietary peptide carrier to increase immunogenicity [33] . Peptide synthesis was performed with a 433A Peptide Synthesizer (Applied Biosystems) using Fmoc chemistry (FastMoc X previous peak method, as suggested by the manufacturer) and TentaGel S RAM (RAPP Polymere, Tübingen, Germany) resin. Cleavage and deprotection were performed by incubation of the resin in 92.5% Trifluoroacetic acid, 5% triisopropylsilane, and 2.5% water for 1.5 h and precipitated in cooled tert-butyl methyl ether. Crude peptides were purified using reversephase high-performance liquid chromatography (HPLC). The correctness of the peptide was confirmed using matrix-assisted laser desorption ionization-time of flight mass spectrometry (4800 series; Applied Biosystems) using a-cyano-4-hydroxycinnamic acid as matrix. The generation of murine anti-SERPINA14 sera was performed by four rounds of immunization (female BALB/c; subcutaneous injections of 100 lg of SERPINA14 per immunization; first immunization with complete Freund adjuvant, and subsequent injections with incomplete Freund adjuvant; time interval 3 wk). Bleeding was performed 10 days after the last injection. . As a control, the transferred proteins were visualized by Ponceau S staining (0.2% [w/v] Ponceau S, 3% trichloroacetic acid, and 3% sulfosalicylic acid in water). The nitrocellulose membrane was blocked overnight in 5% bovine serum albumin (BSA) PBS-T (80 mM disodium hydrogen phosphate, 20 mM sodium dihydrogen phosphate, 100 mM sodium chloride, and 0.1% Tween-20, pH 7.5).
Western Blotting
For immunodetection, a 1:1000 dilution of crude mouse anti-SERPINA14 serum in PBS-T was used. Membranes were incubated for 1 h at room temperature, washed three times for 10 min in PBS-T, and incubated for 1 h in a 1:1000 dilution of horseradish peroxidase (HRP)-conjugated anti-mouse secondary antibody (polyclonal goat anti-mouse immunoglobulins; 1.1 g/L; Dako, Hamburg, Germany). The substrate (SuperSignal West Pico Chemiluminescent; Pierce, Rockford, IL) was used as recommended by the manufacturer. The membrane was exposed to X-ray film (BioMax XAR; Kodak, Rochester, NY).
Mass Spectrometric Identification of SERPINA14
The SDS gel for SERPINA14 identification was prepared using exactly the same conditions as for the Western blot detection of SERPINA14. Instead of a semidry transfer, the gel was Coomassie stained overnight (0.5% , relevant gel bands were excised using a scalpel. Slices were transferred to a 1.5-ml reaction tube and equilibrated twice with 50 mM NH 4 HCO 3 for 10 min. To reduce and block the cysteine residues, the gel slice was incubated for 30 min in 50 mM NH 4 HCO 3 and 45 mM dithiothreitol, pH 8.7, at 558C, followed by two 15-min incubation steps in 50 mM NH 4 HCO 3 with 100 mM iodoacetamide. Prior to digestion, the gel slice was washed twice with water, twice with 50 mM NH 4 HCO 3 , and minced with a pipette tip. Tryptic hydrolysis was performed overnight at 378C in 30 ll of 50 mM NH 4 HCO 3 with 40 ng of porcine trypsin (Promega, Madison, WI). The supernatant was collected and preserved. The peptides were further extracted with 50 ll of 50 mM NH 4 HCO 3 and a subsequent treatment using 50 ll of 70% acetonitrile. The acetonitrile supernatant and the NH 4 HCO 3 fractions were combined and dried using a SpeedVac concentrator (Bachofer, Reutlingen, Germany). Prior to liquid chromatography-tandem mass spectrometry (LC-MS) analysis, peptides were desalted using PepClean C-18 Spin columns (Pierce), as suggested by the manufacturer. The LC-MS was performed on a linear ion trap mass spectrometer coupled online with a two-dimensional chromatographic device (Thermo LTQ with Proteome X; Thermo Electron, San Jose, CA). In the first dimension, strong cation exchange chromatography (SCX) (BioBasic SCX 100 3 0.32 mm column; HPLC-pump Surveyor, flow rate 1000 nl/min; both from Thermo Electron) was performed with five subsequent 20-min linear NH 4 Cl gradients (0-50 mM, 50-100 mM, 100-150 mM, 150-200 mM, and 200-500 mM NH 4 Cl). The fractions were collected onto a trap column (5 3 1 mm; ZORBAX; Agilent, Palo Alto, CA). In the second dimension, reverse-phase chromatography (HPLC-pump Surveyor; BioBasic C18 100 3 0.18 mm column; flow rate, 1000 nl/min; both from Thermo Electron) of each SCX fraction was performed with a linear 72-min gradient (0%-80% solvent B; solvent A: water:acetonitrile:formic acid [v/v/v] 94.9:5:0.1; solvent B: acetonitrile:formic acid [v/v] 99.9:0.1). Mass spectrometry analysis was done with cycles of one MS scan (mass range m/z, 400-1600) and three subsequent data-dependent MS/MS scans (''dynamic exclusion'' activated; collision energy 35%). Finally, the tandem mass spectra were analyzed with Mascot (version 2.1.03; Matrix Science, Boston, MA) using the Metazoa subset of the SwissProt database (release 54.2).
Immunohistochemistry
Tissue samples were fixed in Bouin solution, dehydrated, and embedded in paraffin. Serial sections (3 lm) were cut on a microtome and collected on glass slides. To expose antigenic sites, dewaxed sections were heated at 958C in 10 mM sodium citrate buffer, pH 6.0, for 30 min. Endogenous peroxidase activity was then eliminated by incubation with 0.5% (v/v) H 2 O 2 solution for 15 min. Nonspecific protein binding was eliminated by incubation with 10% normal goat serum. Sections were incubated with the mouse antibody raised against bovine SERPINA14 at a dilution of 1:5000. Incubation was performed overnight at 48C in a humidified chamber, followed by anti-mouse IgG-HRP at 1:400 (2.75 lg/ml; Dako) for 1 h. The peroxidase was made visible by reaction with 0.05% 3,3-diaminobenzidine and 0.0006% H 2 O 2 in 0.13 PBS. Sections were counterstained in Mayer hematoxylin. Controls were performed by replacing primary antibody with mouse preimmune serum. Images were captured on an inverse microscope (DM IRB; Leica, Wetzlar, Germany) equipped with an Olympus DP-72 camera (Hamburg, Germany) using differential interference contrasting technique.
In Vitro Glandular Cell Coculture
Bovine endometrial glands were cultured in Matrigel-coated inserts according to the three-dimensional culture of canine uterine glands described previously [34] , with minor modifications, including the coculture of stromal cells (SCs) in the culture plates underneath the inserts. Bovine uteri from early luteal phase [35] were collected at the local slaughterhouse. The lumen of the ipsilateral horn, dissected from the corpus, was washed with prewarmed PBS without Ca 2þ /Mg 2þ (PBSA). The horn was filled with 20 mM ethylenediaminetetraacetic acid (EDTA) solution, pH 7.4, and incubated for 30 min at 378C. The EDTA solution was removed, and the horn was cut open along the outer side and spread on a tablet. To remove the epithelial cells, the surface of the uterine horn was carefully scraped with a blade. For the preparation of underlying SCs and glandular cells (GCs), a layer of the endometrium was minced and incubated for 2 h (378C) in Dulbecco modified Eagle medium (DMEM)-F12 medium containing 0.4 mg/ml collagenase (Sigma, St. Louis, MO), stirring every 15-20 min. The suspension was then filtered (250 lm) to separate the cells from tissue debris using reusable syringe filter holders (Sartorius, Göttingen, Germany) equipped with 250-lm and 33-lm filters (Bückmann, Mönchengladbach, Germany). The filtrate was loaded on a second filter (33 lm) to separate SCs from GCs, which were held back by the sieve. The cell suspensions of GCs and SCs were washed three times by centrifuging for 8 min at 150 3 g. Finally, the cells were resuspended in DMEM-F12 containing 10% fetal calf serum (Gibco/Invitrogen, Carlsbad, CA). The GC samples were incubated for 3 h in an atmosphere of 5% CO 2 in air to allow the attachment of contaminating SCs. The SCs were seeded in a six-well cell culture plate (Nunclon D Surface; Nunc, Wiesbaden, Germany) and GCs in cell culture inserts (Anopore membrane, 0.2 lm; Nunc) freshly coated with Growth Factor Reduced Matrigel (BD Biosciences, San Jose, CA). The SC medium was changed 18 h after plating, when selective attachment of stromal cells had occurred. Cells were cultured at 378C in a humidified atmosphere of 5% CO 2 in air. Immunocytochemistry using specific antibodies against cytokeratin (for epithelial cells) and vimentin (for the stromal cells) as described previously [36] , showed that the purity of each cell population was greater than 90% (data not shown). When the cells reached 90% confluence, they were cultured serum free for 24 h, after which the stimulation tests of the cells were performed.
The coculture of GCs with SCs was stimulated with P4 (10 ng/ml; Sigma), or E2 (50 pg/ml; Sigma). Recombinant bovine IFNT was applied alone (antiviral activity, 4.8 3 10
3 U/ml medium; PBL Biomedical Laboratories, BOVINE UTERINE MILK PROTEIN AT ESTRUS Piscataway, NJ) or in combination with P4 (P4þIFNT) (P4, 10 ng/ml, þ IFNT, 4.8 3 10 3 U/ml). Medium with the respective diluents served as a control. The cells were harvested after 4 h of stimulation. For this, the medium supernatant in the wells and inserts was discarded, and the GCs were washed with PBSA. A total of 500 ll of TRIzol (Invitrogen) was added, shortly incubated, and mixed vigorously using a pipette. The cell lysates were kept at À808C. RNA was then extracted, and real-time RT-PCR was performed as done for the endometrial tissue samples.
RESULTS
Characterization of the Full-Length SERPINA14 mRNA Sequence
To identify the transcriptional start site of the SERPINA14 gene, sequences derived from cDNA fragments found in our subtracted cDNA libraries [23] and available sequences from the GenBank database were assembled to build a consensus sequence of the SERPINA14 mRNA. This consensus sequence was then compared with the available bovine SERPINA14 mRNA sequence, NM_174797.2, which is based on L22095.1. First, we found that our consensus sequence was longer at the 5 0 end. Additionally, a 5 0 -RACE PCR resulted in a 40-bp longer 5 0 untranslated region containing an additional noncoding exon in contrast to NM_174797.2. Furthermore, the comparison of the consensus to NM_174797.2 showed that NM_174797.2 contained a 39-bp-long repeat in the 3 0 region of the coding sequence that is not present in our consensus sequence (Fig. 1A) . The alignment of the new SERPINA14 mRNA sequence with the bovine genome sequence displayed 100% identity (data not shown). The sequence was subsequently submitted to the EMBL database (GenBank accession no. FM879024). The SERPINA14 gene consists of five exons and is located on the reverse strand of chromosome 21 in a SERPINA gene cluster. It is flanked by the SERPINA11 and SERPINA12 genes (Fig. 1B) . Highest protein sequence similarity to uterine serpins was found for the water buffalo (Bubalus bubalis; 87% identity) and the ovine uterine serpin precursor (NP_001009304; 78% identity). Best similarity to other serpins was found for human SERPINA3 (30% identity).
SERPINA14 Promoter Analysis
The identification of the first small noncoding exon enabled the analysis of the SERPINA14 promoter region. A TATA box and CAAT box motif were identified at À31 and À40 bp upstream of the putative transcriptional start site, respectively.
FIG. 1. A) Differences between our
SERPINA14 consensus sequence (FM879024) and the database sequence L22095 in the 5 0 and 3 0 region of the mRNA. The putative start of exon 1 is indicated (3Exon1, underlined). The translational start site (ATG) is located in exon 2 (.signal peptide, underlined). B) Schematic genomic location and structure of the SERPINA14 gene. The SERPINA14 gene is located on the reverse strand of chromosome 21. Other genes of the SERPINA cluster are shown as dark gray boxes. The coding region of the SERPINA14 gene is shown in black, and the 5 0 and 3 0 untranslated regions are highlighted in gray.
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The genomic region 1 kb upstream of the SERPINA14 transcription initiation site contains a large number of putative elements for transcriptional regulation, including JUN (also known as activator protein 1 [AP-1]) and sex-determining region Y (SRY). One estrogen receptor (ESR1; À274 bp) and several P4 receptors (PGRs; À829, À756, and À470 bp, respectively) binding half-sites were found; however, none were present in a dimeric form necessary for classical steroid receptor DNA binding.
Hormone Profiles of Cyclic and Pregnant Heifers
Peripheral plasma P4 and E2 concentrations of the animals in experiment A at the time of slaughtering were determined ( Fig. 2A) . Animals assigned to the late luteal phase group (18P4H) displayed P4 concentrations .2.8 ng/ml, whereas animals of the early estrus group (18P4L), which were also slaughtered 18 days after estrus, had low P4 concentrations (,0.7 ng/ml). The pregnant groups did not display P4 values significantly different from the nonpregnant counterparts (Fig.  2B ), but E2 was reduced in Day 18 pregnant animals (P ¼ 0.02).
Endometrial SERPINA14 mRNA Expression During the Estrous Cycle and Early Pregnancy
Significant changes of SERPINA14 mRNA were found during the estrous cycle (Fig. 2C) . The highest level of SERPINA14 expression was detected at early (Day 18P4L) and late (Day 0) estrus, displaying a 1728-fold and a 225-fold higher mRNA transcript expression compared with Day 3.5, respectively. The mRNA expression increased subsequently from Day 3.5 to Day 12 and remained moderate during the luteal phase (16-fold and 15-fold at Days 12 and 15,
FIG. 2. A)
In vivo hormone concentrations of P4 and E2 in peripheral blood plasma of cycling control heifers (experiment A) at the day of slaughter. The Day 0 group was slaughtered at estrus around 60 h after induced luteolysis. Animals slaughtered 18 days after estrus were assigned to the late luteal phase group (18P4H) if P4 concentrations were above 2.8 ng/ml, whereas animals of the early estrus group (18P4L), which were also slaughtered 18 days after estrus, had low P4 concentrations (,0.7 ng/ml). Different lowercase letters indicate significant differences between days of the estrous cycle (P , 0.05). B) Progesterone and E2 concentrations in peripheral blood plasma of cycling versus pregnant heifers at the day of slaughtering. Different lowercase letters indicate significant differences between pregnant and control animals (P , 0.05). C) SERPINA14 mRNA concentrations in bovine endometrium during the estrous cycle (n ¼ 4 animals per group): early (Day 18P4L) and late (Day 0) estrus, early luteal (Day 3.5) and luteal (Days 12 and 15) and late luteal (Day 18P4H) phases were analyzed. Results are depicted as means of x-fold mRNA expression 6 SEM related to Day 3.5. Different lowercase letters indicate significant differences between days of the estrous cycle (P , 0.05). D) SERPINA14 mRNA concentrations in bovine endometrium of nongravid controls and early pregnancy (n ¼ 4 animals per group). Results are depicted as means of x-fold mRNA 6 SEM. Significant differences are indicated.
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respectively, compared with Day 3.5). At Day 18, pregnant animals revealed a significant (3.6-fold) higher expression of SERPINA14 in endometrium compared with the cyclic heifers (Fig. 2D) . This difference did not appear at Day 15 between the pregnant and the nonpregnant groups. A pronounced gradient from the cranial uterine horn to the corpus was observed at estrus (7.4-fold, 3.8-fold, and 1.7-fold for cranial, medial, and caudal sections compared with the corpus, respectively; P ¼ 0.01; Fig. 3 ) and, to a lesser extent, at Day 3.5 (P ¼ 0.03; Fig.  3 ). At Days 12, 15, and 18 there was no difference between the various uterine segments in SERPINA14 expression, both in cyclic and pregnant animals (data not shown).
SERPINA14 Protein Expression During the Estrous Cycle
Western blot analysis of uterine flushings revealed a single band at 52 kDa only in animals of the early and late estrus groups (Day 18P4L and Day 0, respectively; A). All cyclic animals displayed much less intensive signals compared with a 150-day pregnant heifer, where additional lower-molecular weight forms appeared (Fig. 4C) . The specificity of the antiserum (Fig. 4, B and D) was confirmed by LC-MS/MS of the bands detected by Western blot analysis (Fig. 4E) .
Hormone Profiles of Heifers after Induced Luteolysis
Peripheral hormone concentrations of P4, E2, and LH ( 800 PGF 2a injection. A subsequent rise of E2 was observed in all animals 36-72 h, followed by an LH peak between 48 and 66 h after induced luteolysis. In two animals, the distinct E2 peak at 48 h was found, but an LH peak could not be detected.
SERPINA14 Protein Expression after Induced Luteolysis
At least one prominent single band at 52 kDa was detected by Western blot analysis of all uterine flushings recovered at 48 and/or 60 h after PGF 2a injection (Fig. 5B) . The SERPINA14 bands displayed different intensities, which did not correlate with P4, the drop of P4, the time of the observed LH peak, the time point of rise of E2, or absolute concentration of E2.
SERPINA14 Protein Localization
Immunoreactive SERPINA14 protein was localized to the glandular epithelium in animals of the early (Day 18P4L) and late (Day 0) estrus group (Fig. 6, A and B) . Luminal epithelium and stroma as well as myometrium were devoid of SERPINA14 staining at all time points examined. SERPINA14 appeared around estrus in deep glandular epithelium only (Fig. 6C) . Neither pregnant animals of Days 15 and 18 nor their nonpregnant controls revealed positive staining. An example of gravid endometrium (Day 150) in Figure 6D showed strong glandular epithelial as well as slight luminal epithelial staining. In corpus luteum tissue of the mid luteal phase, large luteal cells stained positive for SERPINA14 (Fig. 6E) . Incubation with mouse preimmune serum served as negative control (Fig. 6F ).
SERPINA14 mRNA Expression in Uterine GC Coculture
The mRNA expression of SERPINA14 in GCs cocultured with SCs was 1.9 6 0.2-fold (P , 0.0001) increased by E2. As positive control for the stimulatory effect of E2 in our culture system, GJA1 and complement factor C1R mRNA levels were determined and were significantly increased by 4.2 6 1.5-fold (P , 0.01) and 1.7 6 0.2-fold (P , 0.04), respectively. The GCs responded significantly to both P4 and P4þIFNT, showing a 1.5 6 0.2-fold (P , 0.05) increase of SERPINA14 mRNA levels in both cases. The IFNT alone had no effect on SERPINA14 expression, although IFNT significantly stimulated ISG15 mRNA expression (241.5 6 80.6-fold; P , 0.001), demonstrating the ability of cultured glandular epithelial cells to respond physiologically to IFNT.
SERPINA14 mRNA Expression Is Not Restricted to Endometrium
SERPINA14 mRNA abundance varied among different bovine tissues. Next to the uterus, highest expression was detected in corpus luteum and follicles, and minor expression was observed in cumulus-oocyte complexes (Fig. 7) . Specific signals were not detected in oviduct, mammary gland, or further nonreproductive organs analyzed.
DISCUSSION
This report presents the first data suggesting upregulation of SERPINA14 expression by estrogens in the uterine glandular epithelium during estrus. The differences we describe here in SERPINA14 expressions of sheep and cows may indicate species-specific differences, because work on uterine serpins has been conducted mainly in sheep. But given the short time frame around estrus where SERPINA14 was observed in bovine endometrium, this event may simply have been overlooked in other species studied thus far, and therefore it may be physiologically common to many ruminants.
The reconstitution of the SERPINA14 mRNA sequence resulted in prolongation of the 5 0 end of the mRNA, uncovering an additional short noncoding exon. The identification of this noncoding exon 1 allowed the correct analysis of the SERPINA14 promoter sequence. In the 3 0 part of the coding sequence, we observed a deviation from the database sequence [3] that seems to contain a 39-bp-long repeat. This repeat sequence is not present in the genomic sequence. However, our newly obtained consensus sequence shows complete identity with the bovine genomic sequence (Ensembl Btau_4.0 assembly). The uterine serpin genes are highly related (53%-87% identity). Sequence alignment of the uterine serpins to human serpins, however, revealed only moderate similarity resulting from an early evolutionary divergence [37] . The highest sequence similarity was found to members of the human serpin A family (approximately 30% identity).
The present study demonstrates that SERPINA14 is regulated during the estrous cycle in the bovine endometrium. The most abundant mRNA expression at estrus was concomitant with both the detection of immunoreactive SERPINA14 protein in uterine flushing and the positive staining of glandular epithelial cells for SERPINA14. 
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Interestingly, SERPINA14 mRNA was most prominently elevated after the decrease of P4 at the end of the luteal phase. This is in contrast to previous findings of P4 being the key regulator of SERPINA14 expression [2, 9] . The effects of longterm P4 administration have been hypothesized to be caused by a subsequent downregulation of PGR in luminal and glandular epithelium in the absence of estrogens stimulating PGR expression. Because E2 stimulates PGR at estrus [38] , our findings are likewise contradictory to the concept that PGR needs to be abated prior to an induction of SERPINA14 expression [10] . Two independent principles might thus account for SERPINA14 regulation. Although P4 might indirectly regulate SERPINA14 through downregulating PGR, estrogens may directly regulate SERPINA14 in the glandular epithelium in the presence of PGR at estrus.
Analysis of the promoter sequence of the SERPINA14 gene was intended to highlight specific transcription factor-binding sites, especially steroid hormone response elements. No specific dimeric element for either P4 or E2 receptor was found analyzing 1 kb upstream of the transcription start site. However, three half-sites for PGR and one for ESR1 are located close to the transcription start of SERPINA14. Possible estrogen activation might therefore be mediated by other means of modification (e.g., through cofactors) and/or the response of elements for classical steroidogenic effects are located more upstream. Jun elements present in the SERPINA14 promoter domain are bound by transcription factors FOS/JUN, which are regulated through extracellular signals, like growth factors. Because the production of growth factors is enhanced by P4 stimulation, a possible stimulatory role during the luteal phase is feasible. On the other hand, JUN is induced by ESR1 with bound ligand [39] as well as PGR lacking its ligand [40] . Because this is the case for the estrus endometrium in estrus with high levels of both ESR1 and PGR, AP-1 at this specific time point might selectively enhance transcription of SERPINA14. 
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Reporter assays validating the gene segment responsible for transcriptional regulation could be of further use enlightening SERPINA14 activation.
To associate SERPINA14 protein abundance with the dramatic mRNA changes during the estrous cycle, we raised antibodies against bovine SERPINA14 using a synthetic peptide as antigen. In fact, immunoreactive SERPINA14 was present around estrus. The number of cells staining positive was less than observed later during ongoing pregnancy, but the cellular localization was congruent with cumulative vesicles appearing apical in glandular epithelial cells. The localization of SERPINA14 protein in deep glandular epithelium with an absence of luminal epithelial staining is consistent with earlier reports in sheep and cow [10, 11] , although the bovine endometrium around estrus has not been described in detail before. The finding that luminal epithelial cells of the endometrium stained positive in a 150-day pregnant animal is novel to ruminants, and thus an interesting point for further observations. Our antiserum additionally detected immunoreactive protein in uterine flushings obtained from the same earlyestrus animals in which positive immunohistochemical staining was observed. We therefore conclude that SERPINA14 is secreted from the deep uterine glands at estrus into the uterine lumen.
The marked rise in SERPINA14 mRNA abundance between Days 3.5 and 12, which has not been described in other ruminant studies before, can be associated with a rise of peripheral P4. As endometrial PGR decreases during the luteal phase [41] , the absence of PGR during the cycle might as well hold true for luteal-phase changes of SERPINA14 mRNA during the cycle. However, the increase in mRNA levels was not paralleled by an increase of protein expression detectable through Western blotting or immunohistochemistry during the luteal phase of the cycle. It therefore remains unclear whether these mRNA changes are of functional relevance. The prominent mRNA gradient along the uterine horn at Day 0 could not be detected at the protein level. However, if SERPINA14 is secreted rapidly into the lumen, a gradient, which would not be detectable in tissue samples, could still be present in the uterine luminal histotroph.
Consistent with previous reports, many lower-molecular weight forms of SERPINA14 appeared during pregnany [11] . We were able to verify by LC-MS/MS that the detected bands contain SERPINA14-specific peptides, indicating the instability of SERPINA14 is due to protease degradation. The functional relevance of SERPINA14 proteolysis remains to be shown.
Subsequently, we conducted an in vitro approach culturing GCs, those cells in which SERPINA14 protein expression appeared around estrus in vivo. The culture of canine GCs has been recently described to be suitable for studying cyclic events in the uterus, because they preserved glandular structure and steroid receptor expression [34] . The GCs were cocultured with SCs to resemble physiological settings and stimulated for 4 h to observe effects on SERPINA14 mRNA abundance. The most prominent change in mRNA expression was induced by E2 at the physiological concentration of 50 pg/ml, which has been shown recently to appear locally in the endometrium at estrus [42] . Progesterone provoked an increase in mRNA abundance that was less than expected [2] , but the short stimulating interval must be considered. We therefore can consider E2 next to P4 as a putative regulator of SERPINA14 in the bovine endometrium.
The appearance of SERPINA14 at estrus as observed in the present study raises further questions on possible physiological functions. At estrus, the endometrium displays distinct morphological and functional properties. The uterine glands are elongated, and the secretory cells of both luminal and glandular epithelium produce estral mucus. Although capacitation of sperm occurs in the oviduct, where SERPINA14 is not present, an impact on the passing sperm by either activating or repressing developmental competence may be assumed. Given the very abundant but short appearance at estrus together with the mRNA concentration gradient along the uterine horn, SERPINA14 might contribute to transport and survival of sperm (e.g., through modulation of the maternal immune system).
A modulation of lymphocyte proliferation and transformation in sheep has been characterized in association with a protection of the fetal allograft during ongoing pregnancy [43] . A protection of sperm from immigrating immune cells is conceivable, especially during estrus, where CD4 þ and CD8 þ T cells increase markedly within the luminal and glandular epithelia and in the stratum compactum [44] . The immune defense mechanisms might need to be abated in order to allow sperm passage [45] . As in our previous studies [25, 46] , we found in this animal cohort an increase in SERPINA14 mRNA in the pregnant animals at Day 18. Interferon-s, a type I interferon, has been demonstrated as the most important pregnancy recognition signal in ruminants [47, 48] . Although there was no difference in SERPINA14 mRNA levels between pregnant and nonpregnant animals at Day 15, when IFNT is already abundant in vivo, the hypothesis was tested if this significant increase in mRNA at Day 18 was due to IFNT secreted by the embryo. In the 1-kb promoter region analyzed, there was neither an interferon-stimulated response element nor a gamma-interferon-activated sequence. In our cell culture experiment, IFNT alone or in combination with P4, compared with vehicle and P4 alone, respectively, did not cause alterations of SERPINA14 mRNA expression. In vivo, E2 and P4 plasma levels were not different between pregnant and control animals. Therefore, steroids causing differential expression cease to apply, and an assignable cause for the upregulation of SERPINA14 during early pregnancy remains to be unraveled. The lack of detectable SERPINA14 protein during early pregnancy might indicate that the relevance of rising SERPINA14 prior to implantation could be rather small. But the protein concentration could also be below the detection limit of the antibody. Interestingly, ovine SERPINA14 has been shown to inhibit the development of preimplantation blastocysts [18] . The induction of SERPINA14 gene expression at Day 18 of pregnancy might therefore mark the end of elongation of the trophoblast. Pemberton et al. [49] described typical conformational changes during an inflammation for those serpins that are hormonebinding globulins (thyroxine and cortisol-binding globulin). When these molecules undergo the change from the stressed to the relaxed form, they are able to bind and release the carried molecules at specific locations.
Although initially described as specific to the endometrium, SERPINA14 expression was found not to be restricted to the endometrium. The presence was demonstrated in fetal fluids as well as caruncles [50, 51] . Screening transcript abundance in different organs, other female reproductive tissues, specifically corpus luteum, as well as follicles appeared moderately positive, whereas all other organs examined were negative. The moderate mRNA expression in the corpus luteum was furthermore verified on the protein level with our antibody targeting large luteal cells. Large luteal cells are functionally involved in P4 synthesis, and there is evidence that P4 acts on the CL as an autocrine or paracrine regulator in a stagedependant fashion [52] . As PGR and ESR1 are expressed in the corpus luteum [53] , luteal SERPINA14 might be regulated by BOVINE UTERINE MILK PROTEIN AT ESTRUS steroids. With respect to immune function, SERPINA14 might help to protect the corpus luteum from tumor necrosis factormediated infiltrating immune cells associated with luteolysis. A thorough investigation of the distribution of SERPINA14 in the cycling and early pregnant corpus luteum might unravel yetunknown aspects of SERPINA14 function.
In summary, our data suggest that estrogens stimulate SERPINA14 expression during estrus in glandular epithelial cells of the bovine endometrium and show that SERPINA14 is secreted in the bovine uterine lumen. The precise timing around the period of mating may be of functional relevance concerning the preparation of the site of gamete development prior to fertilization.
